InsidersTradesSigma
Follow the SK바이오사이언스 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, SK바이오사이언스 has published 2 public disclosures. Market capitalisation: €2,698.9bn. The latest transaction was disclosed on 27 March 2026 (Purchase). Among the most active insiders: SK케미칼. Every trade is accessible without an account.
2
Insider Decl.
n/a
Thresholds
€115,619
2 ops.
Buy Volume
n/a
n/a
Sell Volume
10Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,640 of 29,063 companies
20.1
score / 100
Value24
Quality17
FCF yld-5.8%
Earn yld-2.1%
EV/EBITDA·
ROE-4.3%
Gross mgn12%
Net mgn-8.8%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 27 March 2026
Acerca de SK바이오사이언스
SK Bioscience es una empresa surcoreana centrada en el desarrollo y la fabricación de vacunas y productos biológicos. Cotiza en el mercado XKRX.